BACTERIOSTATIC NATURE OF ERYTHROMYCIN

ABSTRACT







Erythromycin is antibiotics
produced from a strain ofStreptomyces erythreus



 (later changed to "Saccharopolyspora

erythraea") which belongs to the group of macrolides which tends to
inhibit the growth/development of bacteria. It sometimes exhibits bactericidal
characteristics when administered in high concentration. It carries out its
bacteriostatic actions by binding to the 23s RNA component of the 50s ribosome
of the bacteria, thereby interfering with the assembly of the 50s subunits of
the bacteria cell. Erythromycin is mostly administered orally because it comes
mostly in capsules, oral suspensions and tablets but can be given intravenously
through injection. It is used in the treatment of infection caused by
gram-positive cocci eg Streptococcus

pyogenes, Staphylococcus aureus, Entamoeba histolytica and some others. Erythromycin
leads to complications in the body when used prolongly; such adverse effects
may include gastrointestinal disturbances ( eg vomiting, nausea, diarrhea,
abdominal pain) , hepatotoxicity in mostly pregnant women and pyloric stenosis
in young infants.







 

Overall Rating

0

5 Star
(0)
4 Star
(0)
3 Star
(0)
2 Star
(0)
1 Star
(0)
APA

Okoro, O. (2018). BACTERIOSTATIC NATURE OF ERYTHROMYCIN. Afribary. Retrieved from https://tracking.afribary.com/works/bacteriostatic-nature-of-erythromycin-4171

MLA 8th

Okoro, Obinna "BACTERIOSTATIC NATURE OF ERYTHROMYCIN" Afribary. Afribary, 29 Jan. 2018, https://tracking.afribary.com/works/bacteriostatic-nature-of-erythromycin-4171. Accessed 22 Nov. 2024.

MLA7

Okoro, Obinna . "BACTERIOSTATIC NATURE OF ERYTHROMYCIN". Afribary, Afribary, 29 Jan. 2018. Web. 22 Nov. 2024. < https://tracking.afribary.com/works/bacteriostatic-nature-of-erythromycin-4171 >.

Chicago

Okoro, Obinna . "BACTERIOSTATIC NATURE OF ERYTHROMYCIN" Afribary (2018). Accessed November 22, 2024. https://tracking.afribary.com/works/bacteriostatic-nature-of-erythromycin-4171